Effect of Pioglitazone on TIMP-3 and TACE in Type 2 Diabetes
Condition(s):Type 2 DiabetesLast Updated:January 11, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 DiabetesLast Updated:January 11, 2016Completed
Condition(s):Head and Neck Cancer; Oral LeukoplakiaLast Updated:February 11, 2022Completed
Condition(s):Prostate Cancer; Insulin Resistance; Diabetes Mellitus, Type 2; Androgen DeficiencyLast Updated:August 15, 2023Withdrawn
Condition(s):Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:January 9, 2019Terminated
Condition(s):Type 2 Diabetes MellitusLast Updated:March 12, 2019Completed
Condition(s):Mild Cognitive Impairment Due to Alzheimer’s DiseaseLast Updated:July 2, 2019Terminated
Condition(s):Depressive Disorder, Major; Metabolic Syndrome XLast Updated:January 26, 2017Completed
Condition(s):Thyroid Cancers That Contain the PAX8-PPARgamma Fusion GeneLast Updated:October 26, 2017Completed
Condition(s):Stage IA Non-Small Cell Lung Carcinoma; Stage IB Non-Small Cell Lung Carcinoma; Stage IIA Non-Small Cell Lung Carcinoma; Stage IIB Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung CancerLast Updated:December 5, 2017Terminated
Condition(s):Chronic Kidney DiseasesLast Updated:May 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.